LegisTrack
Back to all bills
SRES 464119th CongressIntroduced

A resolution designating September 2025 as "National Cholesterol Education Month" and September 30, 2025, as "LDL-C Awareness Day".

Introduced: Oct 23, 2025
Sponsor: Sen. Hyde-Smith, Cindy [R-MS] (R-Mississippi)
Standard Summary
Comprehensive overview in 1-2 paragraphs

S. Res. 464 is a non-binding Senate resolution that formally designates September 2025 as "National Cholesterol Education Month" and September 30, 2025, as "LDL-C Awareness Day." Its primary purpose is to raise public awareness about the critical role of low-density lipoprotein cholesterol (LDL-C), often called "bad cholesterol," in causing cardiovascular disease—the leading cause of death in the United States. The resolution highlights significant gaps in care, including low rates of LDL-C testing after heart events (especially among African-American patients), poor treatment adherence, and disparities in outcomes between rural and urban populations. While it does not create new laws, funding, or programs, it aims to catalyze action by urging individuals to know their LDL-C numbers and recognizing the urgent need for improved screening and treatment to prevent heart attacks and strokes.

Key Points

  • 1Encourages all U.S. individuals to know their LDL-C number, emphasizing it as a key modifiable risk factor for cardiovascular disease.
  • 2Officially designates September 2025 as "National Cholesterol Education Month" to focus national attention on cholesterol-related health risks.
  • 3Designates September 30, 2025, specifically as "LDL-C Awareness Day" to highlight the importance of this particular type of cholesterol.
  • 4Recognizes the urgent need for improved screening and treatment of elevated LDL-C to reduce cardiovascular events like heart attacks and strokes.
  • 5Cites critical data gaps, including that 71% of high-risk patients never reach LDL-C treatment goals and only 27% of heart attack patients receive recommended follow-up LDL-C testing.

Impact Areas

General public health awareness and individual health behaviors regarding cholesterol management.High-risk populations, particularly rural residents (with 40% higher cardiovascular disease prevalence) and African-American adults (who face disparities in post-hospitalization testing despite higher disease rates).Healthcare system practices, by spotlighting failures in guideline adherence for LDL-C testing and treatment, potentially influencing provider education and patient follow-up protocols.
Generated by Qwen3 235B A22B (qwen) on Oct 28, 2025